Global Stocks Tank Amid North Korea, China Worries A

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz goarmy123 #7458
Global Stocks Tank Amid North Korea, China Worries
A possible nuclear test in North Korea and lingering concerns over China worry investors
By Riva Gold
Updated Jan. 6, 2016 7:28 a.m. ET
0 COMMENTS

Concerns over China, news of a possible nuclear test in North Korea and a steep fall in oil prices combined to send global stocks lower on Wednesday, extending the shaky start to this year.

Futures pointed to a 1.4% opening loss for the S&P 500. Changes in futures do not necessarily reflect market moves after the opening bell.

The Stoxx Europe 600 was down 1.2% late morning, led lower by the resources sector as Brent crude fell to an 11-year low and the price of copper declined.

Investors shed risky assets and bought into haven investments, spooked by lackluster Chinese services data released on Wednesday. Those concerns were a large factor in oil’s decline, as mounting concerns over China’s economy spread across markets.

“The slowdown in China and its effect more broadly on emerging markets will still be a major theme in the global equity market this year,” said David Lafferty, chief market strategist at Natixis Global Asset Management

The Shanghai Composite Index ended up 2.3% Wednesday, but its near 7% plunge at the start of the week has left investors on edge.
Related

Oil Prices Fall to 11-Year Low
Gold Rises Amid Tensions
What to Watch in the Fed’s December Minutes

China’s central bank has intervened in markets to soothe fears and prop up the country’s economy. On Wednesday, the bank fixed the yuan at a five-year low against the U.S. dollar. Regulators also tried to reassure markets that a ban on selling stocks by large stakeholders due to expire on Friday will not have the catastrophic effect that many in the market fear.
Advertisement

For European equities “China is the only story,” said Tristan Abet, investment strategist at Louis Capital Markets. “If you’re a bear on China and the yuan, you can’t be bullish on Europe,” he said.

Elsewhere in Asian trade, Australia’s S&P ASX 200 fell 1.2%, while Hong Kong’s Hang Seng Index fell 1%, deepening a week of losses for both indexes.

Japan’s Nikkei Stock Average closed down 1%.
A news report in South Korea about an earthquake near North Korea's nuclear facility on Wednesday. ENLARGE
A news report in South Korea about an earthquake near North Korea's nuclear facility on Wednesday. Photo: Associated Press

Adding to the investors’ concerns, North Korea on Wednesday said it successfully staged its first test of a more powerful form of nuclear weapon.

“On the political front, confirmation of an apparently successful nuclear test by North Korea weighed on already fragile sentiment in the region,” Sam Hill, an economist at RBC Capital Markets, wrote in a note.

Among traditional safe haven assets, gold was up 0.5% at $1,083.30 a troy ounce, and the yen neared a three-month high against the dollar.

Investors also moved into the relative safety of government debt. Ten-year U.S. Treasury yields were 0.04 percentage point lower at 2.196% and 10-year German yields fell by a similar amount to 0.504%. Yields fall as prices rise.

In commodities, Brent crude fell 3.6% to $35.10 a barrel. The fall is ahead of weekly U.S. crude inventory and production data later in the day. In metals, copper was down 0.4% at $4625 a metric ton in London trade.i can

Commodity investors also continue to weigh a strong dollar, recent tensions between Saudi Arabia and Iran, and the latest manufacturing releases from China and the U.S.

Commodities-linked stocks were helping to lead Europe lower. European energy stocks were last down 1.4%, while the basic materials sector was down 2.8%. Shares in BHP Billiton were down 4.8% and Rio Tinto PLC lost 4.1%.

The euro was down 0.1% against the dollar at $1.0729 after the eurozone composite purchasing managers index was revised up. The dollar was last down 0.6% against the yen at ¥118.4380.

Wall Street closed a touch higher on Tuesday, as markets steadied after a sharp selloff earlier in the week.

Later Wednesday, investors will parse the ADP employment report and U.S. trade gap data for clues on the health of the U.S. economy.
Federal Reserve Chairwoman Janet Yellen speaks at a news conference in Washington D.C. last month. ENLARGE
Federal Reserve Chairwoman Janet Yellen speaks at a news conference in Washington D.C. last month. Photo: Bao Dandan/Zuma Press

Investors will also be returning to the subject that dominated trade last year: U.S. monetary policy. Minutes from the U.S. Federal Reserve’s December policy meeting, where officials voted to raise benchmark interest rates for the first time in nearly a decade, will be released later Wednesday.

If there is any more detail around what Janet Yellen means by a “gradual” path for future interest rate increases, that will definitely have implications for equity markets over the course of the year, said Mr. Lafferty.

“Any indication that they’re in a hurry to raise rates [will be] bad for stocks,” he said.
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 22

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 22

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 22

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 23

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 24

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Asia Midday Update: Stock Market Movements and Trends

Updated Category News Views 234

Asia Midday Stock Market Insights During the recent stock market activity, the US stock market showed resilience despite facing renewed tariff discussions. Major indices experienced a breakout from previous consolidations, primarily driven by a significant 2.8% increase in Nvidia (NASDAQ: NVDA). This surge was notable as Nvidia achieved a remarkable milestone, being the...

Continue Reading
Fibocom Pushes AIoT Innovation at ElectroneX 2026

Updated Category News Views 11

What's the Buzz About Fibocom at ElectroneX? Some folks are really shaking things up over at ElectroneX 2026 in Sydney. Fibocom's out there flexing their latest AIoT wares, and the scene's ripe with promise. Under the catchy theme "Intelligent Connectivity for a Smarter World," you're seeing wireless solutions that scream innovation—speaking right to the heart of the...

Continue Reading
Transforming $100 into Significant Gains with Nike's Growth

Updated Category News Views 34

Transforming $100 into Significant Gains with Nike's Growth Nike (NYSE: NKE) has consistently delivered impressive performance in the stock market over the past two decades. With an annualized return of 11.56%, it has outperformed many other investments, showcasing its strong market presence and growth potential. As of now, Nike boasts a market capitalization of an...

Continue Reading
Modern Lion and Hyundai Card Partner to Transform Concerts

Updated Category News Views 60

Revolutionizing Concert Experiences with NFT Integration Modern Lion is embarking on a transformative journey by launching KONKRIT, an innovative platform for NFT-based ticketing, in partnership with Hyundai Card and NEAR Protocol. This collaboration is set to redefine how we experience concerts, paving the way for secure ticket purchases and enhanced event engagement....

Continue Reading
Verisk Analytics Faces Analyst Downgrades Following Q3 Report

Updated Category News Views 177

Verisk Analytics Reports Third Quarter Results Verisk Analytics, Inc. (NASDAQ:VRSK) has recently revealed its third-quarter financial performance, showcasing a mix of ups and downs that have caught the attention of analysts across the industry. Financial Performance Overview The company declared quarterly earnings of $1.72 per share, surpassing the consensus estimate by a...

Continue Reading